Healthcare -
Biotechnology - NASDAQ - GB
$ 1.26
0.00794 %
$ 42.7 M
Market Cap
-3.32
P/E
OKYO - COST OF REVENUE
Cost of Revenue OKYO - OKYO Pharma Limited
7.51 K
LAST VALUE
76.01%
2 YEAR CAGR
102.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR